Once-daily, effective, safe, and well-tolerated ZORYVE cream 0.05% now commercially available for children as young as age 2ZORYVE cream 0.05% ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the launch of AdvanceAD-Tx™, a gene expression profile (GEP) test ...

More than 31 million people in the U.S. live with eczema, a chronic skin condition that can disrupt daily life yet continues ...

JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, today announced that the U.S. Food and Drug ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. has initiated a new clinical study titled ‘A Phase 3, ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 2B clinical study titled ‘A PHASE 2B, ...

COVID-19 vaccination may help children with eczema fight infections and allergies, offering protection that goes far beyond ...

Nearly 50% of survey respondents living with atopic dermatitis (AD) report a severe impact on their quality of life, yet 79% of patients surveyed find their current treatment approaches ineffective. 1 ...

Please provide your email address to receive an email when new articles are posted on . Zerigo 2.0 ecosystem assists in the treatment of chronic skin conditions at home or on the go in half the time ...

ZORYVE cream 0.05% provides rapid and effective relief of mild to moderate atopic dermatitis in children ages 2 to 5 and is safe and well tolerated Once-daily, steroid-free cream can be used anywhere ...